BCNU (1,3), BIS(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia
- 1 August 1968
- Vol. 22 (2), 451-456
- https://doi.org/10.1002/1097-0142(196808)22:2<451::aid-cncr2820220224>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animalsClinical Pharmacology & Therapeutics, 1967
- The Antitumor Agent, 1,3-bis(2-chloroethyl)-1-nitrosoureaJournal of Pharmaceutical Sciences, 1966
- Mechanisms of Drug Absorption and Excretion Passage of Drugs in and out of the Central Nervous SystemAnnual Review of Pharmacology, 1962
- Effect of Diazoalkane-yielding Compounds on Strains of Escherichia coli Resistant to 1-Methyl-3-nitro-1-nitrosoguanidine.Experimental Biology and Medicine, 1960